Global Anti-Asthmatics and COPD Drugs Market is Forecast to Grow at a CAGR of 48.8% Between 2019 and 2020, Following COVID-19 Outbreak – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Anti-Asthmatics and COPD Drugs Global Market Report 2020-30: COVID-19 Implications and Growth” report has been added to ResearchAndMarkets.com’s offering.

The global anti-asthmatics and COPD drugs market is expected to grow from $52 billion in 2019 to $77.3 billion in 2020 at a compound annual growth rate (CAGR) of 48.8%. The respiratory drugs market witnessed significant growth mainly due to the COVID-19 outbreak. The fact that Covid-19 is essentially a respiratory ailment has boosted the market growth. The market is then expected to grow at a CAGR of 5.7% from 2021 and reach $83.8 billion in 2023.

The anti-asthmatics and chronic obstructive pulmonary disease (COPD) market consists of sales of anti-asthmatics and chronic obstructive pulmonary disease (COPD) drugs which are used to relieve the frequency of acute attacks of asthma, emphysema, chronic bronchitis, and nocturnal awakenings. The class of drugs includes Bronchodilators, anti-inflammatory drugs, monoclonal antibodies and combination drugs.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

• The Market Characteristics section of the report defines and explains the market.

(Read more…)

• The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
• Market segmentations break down market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Key Topics Covered:

1. Executive Summary

2. Anti-Asthmatics And COPD Drugs Market Characteristics

3. Anti-Asthmatics And COPD Drugs Market Size And Growth

4. Anti-Asthmatics And COPD Drugs Market Segmentation

5. Anti-Asthmatics And COPD Drugs Market Regional And Country Analysis

6. Asia-Pacific Anti-Asthmatics And COPD Drugs Market

7. China Anti-Asthmatics And COPD Drugs Market

8. India Anti-Asthmatics And COPD Drugs Market

9. Japan Anti-Asthmatics And COPD Drugs Market

10. Australia Anti-Asthmatics And COPD Drugs Market

11. Indonesia Anti-Asthmatics And COPD Drugs Market

12. South Korea Anti-Asthmatics And COPD Drugs Market

13. Western Europe Anti-Asthmatics And COPD Drugs Market

14. UK Anti-Asthmatics And COPD Drugs Market

15. Germany Anti-Asthmatics And COPD Drugs Market

16. France Anti-Asthmatics And COPD Drugs Market

17. Eastern Europe Anti-Asthmatics And COPD Drugs Market

18. Russia Anti-Asthmatics And COPD Drugs Market

19. North America Anti-Asthmatics And COPD Drugs Market

20. USA Anti-Asthmatics And COPD Drugs Market

21. South America Anti-Asthmatics And COPD Drugs Market

22. Brazil Anti-Asthmatics And COPD Drugs Market

23. Middle East Anti-Asthmatics And COPD Drugs Market

24. Africa Anti-Asthmatics And COPD Drugs Market

25. Anti-Asthmatics And COPD Drugs Market Competitive Landscape And Company Profiles

26. Key Mergers And Acquisitions In The Anti-Asthmatics And COPD Drugs Market

27. Anti-Asthmatics And COPD Drugs Market Trends And Strategies

28. Product Pipeline Analysis

29. Anti-Asthmatics And COPD Drugs Market Future Outlook and Potential Analysis

Companies Mentioned

• Novartis AG
• Merck & Co
• GlaxoSmithKline
• Boehringer Ingelheim Gmbh
• AstraZeneca
• Roche
• Teva Pharmaceutical
• Vectura
• Pfizer
• Abbott
• Mylan
• Allergan
• Cipla
• Akorn

For more information about this report visit https://www.researchandmarkets.com/r/i4k83t

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900